Royalty Pharma Variance
| RPRX Stock | | | USD 46.92 -0.02 -0.04% |
Observed values used in the Variance indicator for Royalty Pharma Plc are included in this dataset. Comparable indicator datasets are structured within
Equity Screeners. Royalty Pharma has a market cap of 27.2 B, operating margin of 57.68%, current ratio of 2.07. Review
Your Equity Center for a broader allocation view. Monitoring Royalty Pharma Plc within a portfolio highlights how it interacts with other holdings. Rebalancing tools flag when weights drift from target allocations. Broader economic conditions can influence Royalty Pharma Plc's company valuation — related indicators include
signals in real.
Royalty Pharma Plc has current Variance of 1.41. Variance is another measure of security risk that shows the amount of dispersion of equity returns around their mean value. Variance is calculated as the average squared deviations from the mean. Evaluating a set of investment alternatives one can use variance to help determine the volatility when purchasing a specific security. Similar to Standard Deviation, the variance is a measure of how far a set of numbers is spread out around its mean.
Variance | = | SUM(RET DEV)2N |
| = | 1.41 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual returns deviation over selected period |
| N | = | Number of points for the period |
Variance Peers Comparison
Variance Relative To Other Indicators
Royalty Pharma Plc is rated
below average in variance among leading competitors. It is currently under evaluation in maximum drawdown among leading competitors reporting about
4.55 of Maximum Drawdown per Variance. At
4.55 , Royalty Pharma Plc's Maximum Drawdown-to-Variance multiple reflects the spread between these metrics
Variance is also a measure of stock volatility and can help determine the risk an investor might take on when purchasing a specific security. A relatively big variance indicates that the daily prices or returns are far from the mean and a small variance indicates that they are located around the mean.
Compare Royalty Pharma to Peers
Other Technical Indicators